Trump is sold on psychedelic therapy. What does the science say?
Briefly

Trump is sold on psychedelic therapy. What does the science say?
"For years when most people thought about psychedelic drugs, they pictured long-haired tripping hippies either having a ball or risking and wasting their lives, depending on the tenor of the anti-drug messaging one happened to be subject to."
"When science ceded psychedelics to the counterculture movement, it abandoned promising results on the power of these drugs to change human minds for the better."
"Johns Hopkins University received the first regulatory approval to resume the study of psychedelics in the U.S., kicking off a full-blown psychedelics renaissance."
"Last month President Donald Trump signed an executive order aimed at accelerating access to psychedelic drugs, raising questions about its implications for researchers in the booming field."
Psychedelic drugs were historically associated with counterculture and negative public opinion, leading to a halt in scientific research. However, Johns Hopkins University resumed studies in the early 21st century, initiating a renaissance in psychedelic research. These substances, previously viewed as recreational, are now being investigated for their therapeutic potential in treating conditions like PTSD, depression, and substance-use disorders. Recent government actions, including an executive order by President Trump, aim to accelerate access to these drugs for research purposes.
Read at www.scientificamerican.com
Unable to calculate read time
[
|
]